MedTrace Logo

Eye Movement Testing for Diagnosing Encephalopathy in Patients With Liver Disease

NCT04940416 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2021-06-25

No results posted yet for this study

Summary

This study involves utilizing a noninvasive computer application (Neurofit) that performs oculometric assessment of dynamic visual processing in patients with liver cirrhosis to see if the presence of advance liver disease influences eye movement metrics.

Conditions

  • Cirrhosis
  • Hepatic Encephalopathy

Interventions

DEVICE

Neurofit (oculometric testing)

The Neurofit test involves sitting on a chair with a head and chin rest to maintain stability. Patients will then follow a moving object on the computer screen with their eyes which allows estimation of individual oculometrics along with a composite score. No physical contact or placement of invasive devices will be performed. The total time for completion of all the tests is estimated at 30 minutes.

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-31
Primary Completion
2021-06-17
Completion
2021-06-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04940416 on ClinicalTrials.gov